Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Endometrial Tumors (POET)

NCT00566644 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT00566644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00566644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Endometrial Tumors (POET)
Lead sponsor
St George's, University of London
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2007
Completion date
August 31, 2009
Enrollment
600 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)